Disruption of the AR/filamin A complex using a stapled peptide effectively reduces CAF invasiveness and tumor growth in co-culture models, suggesting the potential for targeting this complex as a therapeutic strategy to enhance treatment outcomes in prostate cancer (48, 49). The gene discussed is FLNA; the disease is Familial prostate cancer.